Valuation (47%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 29.00 | 22.53 |
| PEG Ratio (TTM) | -3.11 | -15.87 |
| P/S Ratio (TTM) | 0.40 | 4.97 |
| P/B Ratio (TTM) | 1.45 | 4.19 |
| P/FCF Ratio (TTM) | 35.50 | 3.63 |
| Price to 5YR AVG Earnings Ratio | 35.93 | 25.51 |
| Price to 5YR AVG FCF Ratio | 126.78 | 27.80 |
Profitability (20%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 2.21% | 2,872.47% |
| ROE (TTM) | 5.12% | 29.95% |
| Net Profit Margin (TTM) | 1.35% | 24.71% |
| ROIC 5YR AVG | 5.39% | 14.40% |
Growth (50%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 205.40% | 36.55% | -228.00% |
| Revenue | -0.90% | -5.44% | -2.03% |
| Net Income | 206.72% | 37.09% | -229.04% |
| Cash Flow | 44.56% | -68.76% | 49.42% |
Health (68%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.38 | 0.91 |
| Quick Ratio (TTM) | 1.38 | 0.86 |
| D/E Ratio (TTM) | 0.59 | 17.20 |
| Interest Coverage (TTM) | 1.94 | 8.71 |
| Piotroski F-Score | 7 | 6 |
| Altman Z-Score | 3.42 | 2.42 |
| LTL to 5YR AVG FCF | 39.20 | 6.49 |
| Shares Outstanding Growth 5YR AVG | 0.83% | -0.31% |